PR3 can also cleave TNF-α [90], a key cytokine in inflammation, as evidenced by the successful use of anti-TNF-α treatments for Crohn’s disease, rheumatoid arthritis, and psoriasis [91]. The gene discussed is TNF; the disease is rheumatoid arthritis.